ES2195939T3 - Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba. - Google Patents

Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba.

Info

Publication number
ES2195939T3
ES2195939T3 ES00969811T ES00969811T ES2195939T3 ES 2195939 T3 ES2195939 T3 ES 2195939T3 ES 00969811 T ES00969811 T ES 00969811T ES 00969811 T ES00969811 T ES 00969811T ES 2195939 T3 ES2195939 T3 ES 2195939T3
Authority
ES
Spain
Prior art keywords
carnitine
ginkgo biloba
composition
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00969811T
Other languages
English (en)
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau HealthScience SpA
Original Assignee
Sigma Tau HealthScience SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau HealthScience SpA filed Critical Sigma Tau HealthScience SpA
Application granted granted Critical
Publication of ES2195939T3 publication Critical patent/ES2195939T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición de combinación, que se caracteriza por contener como ingredientes activos: (a) una mezcla de L-carnitina (LC), acetil L-carnitina (ALC) y propionil L-carnitina (PLC) o de las sales farmacológicamente aceptables de las mismas; y (b) un extracto de Ginkgo biloba o uno o más ginkgólidos aislados del mismo o mezcla de los mismos.
ES00969811T 1999-10-08 2000-10-02 Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba. Expired - Lifetime ES2195939T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000618A IT1306722B1 (it) 1999-10-08 1999-10-08 Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di

Publications (1)

Publication Number Publication Date
ES2195939T3 true ES2195939T3 (es) 2003-12-16

Family

ID=11406992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00969811T Expired - Lifetime ES2195939T3 (es) 1999-10-08 2000-10-02 Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba.

Country Status (21)

Country Link
US (1) US6641849B1 (es)
EP (1) EP1218022B1 (es)
AR (1) AR025790A1 (es)
AT (1) ATE237341T1 (es)
AU (1) AU780643B2 (es)
CA (1) CA2386770C (es)
CZ (1) CZ20021062A3 (es)
DE (1) DE60002226T2 (es)
DK (1) DK1218022T3 (es)
ES (1) ES2195939T3 (es)
HU (1) HU227042B1 (es)
IL (1) IL148963A0 (es)
IT (1) IT1306722B1 (es)
MX (1) MXPA02003501A (es)
NO (1) NO20021640L (es)
PL (1) PL199996B1 (es)
PT (1) PT1218022E (es)
SK (1) SK4052002A3 (es)
TN (1) TNSN00186A1 (es)
TR (1) TR200200948T2 (es)
WO (1) WO2001026666A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
IT1317035B1 (it) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti dal
CA2439078C (en) * 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
ITRM20010708A1 (it) * 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US7935714B2 (en) 2004-05-18 2011-05-03 Bright Future Pharmaceutical Laboratories Compositions for sleeping disorders
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
ITRM20040561A1 (it) * 2004-11-11 2005-02-11 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
AR070816A1 (es) * 2008-03-14 2010-05-05 Otsuka Pharma Co Ltd Farmaco de combinacion para tratar trastornos vasculares
EA019237B1 (ru) * 2008-11-11 2014-02-28 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. Соединения, пригодные для лечения целлюлита
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
CZ308282B6 (cs) * 2010-08-05 2020-04-15 Výzkumný ústav živočišné výroby, v. v. i. Krmný doplněk pro zvýšení libida kanců
CN102783568B (zh) * 2012-08-29 2014-05-14 山东中医药大学 一种饲料添加剂
PL2952209T3 (pl) 2014-06-04 2018-07-31 Alfasigma S P A Jednorodne formulacje zawierające wielonienasycone kwasy tłuszczowe omega-3 (n-3 PUFA) i resweratrol do podawania doustnego

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
DE9318632U1 (de) * 1993-12-06 1995-04-06 Wulf & Co Emsa Werk Vorrichtung zum Aufnehmen von Folienrollen
US6221356B1 (en) * 1996-12-13 2001-04-24 Viva America Marketing, Inc. Method of preparation of biologically active Ginkgo biloba product
JP2001511153A (ja) 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
IT1294227B1 (it) 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.

Also Published As

Publication number Publication date
PL354413A1 (en) 2004-01-12
IT1306722B1 (it) 2001-10-02
IL148963A0 (en) 2002-11-10
TR200200948T2 (tr) 2002-10-21
ITRM990618A1 (it) 2001-04-08
DE60002226D1 (de) 2003-05-22
EP1218022A2 (en) 2002-07-03
WO2001026666A2 (en) 2001-04-19
MXPA02003501A (es) 2002-09-02
NO20021640L (no) 2002-05-29
AU780643B2 (en) 2005-04-07
SK4052002A3 (en) 2002-09-10
PT1218022E (pt) 2003-09-30
US6641849B1 (en) 2003-11-04
ITRM990618A0 (it) 1999-10-08
TNSN00186A1 (fr) 2005-11-10
DE60002226T2 (de) 2004-03-04
PL199996B1 (pl) 2008-11-28
AU7945600A (en) 2001-04-23
CA2386770C (en) 2009-09-08
CZ20021062A3 (cs) 2002-08-14
EP1218022B1 (en) 2003-04-16
NO20021640D0 (no) 2002-04-05
WO2001026666A3 (en) 2001-09-13
HUP0203449A2 (hu) 2003-02-28
HUP0203449A3 (en) 2005-04-28
DK1218022T3 (da) 2003-08-11
AR025790A1 (es) 2002-12-11
CA2386770A1 (en) 2001-04-19
HU227042B1 (en) 2010-05-28
ATE237341T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
ES2195939T3 (es) Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ECSP066313A (es) Derivados de la piridazina y su uso como agentes terapéuticos
BR9306393A (pt) Suplemento natural e processo para melhorar a saúde de um ser humano
AR018924A1 (es) Composicion para la prevencion y/o tratamiento de osteoporosis y alteraciones debidas al sindrome de menopausia
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ECSP034922A (es) Pirrolopirimidinas
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
AR028959A1 (es) Uso de rapamicina para la manufactura de un medicamento para tratar enfermedades cardiovasculares
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
AR013001A1 (es) Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina.
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
PT1414473E (pt) Composicoes de administracao oral para o tratamento de disturbios do couro cabeludo
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
AR026254A1 (es) El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4
NO20013787D0 (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
AR008506A1 (es) Composicion farmaceutica.
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
AR040737A1 (es) Administracion oral de calcitonina
AR024981A1 (es) Composicion para la prevencion y el tratamiento de las disfunciones y enfermedades del rinon
PT1007034E (pt) Combinacoes que contem bergamotina para aumentar a biodisponibilidade oral de agentes farmaceuticos
BR0014263A (pt) Preparação antioxidante baseada em extratos vegetais para o tratamento de problemas degenerativos crÈnicos e circulatórios e de hipertensão
NO20044519L (no) Hyperforinderivater, anvendelse derav samt formuleringer som inneholder dem
HRP20040165B1 (en) Citalopram for the treatment of elevated blood pressure